JPS5421326B2 - - Google Patents
Info
- Publication number
- JPS5421326B2 JPS5421326B2 JP7490277A JP7490277A JPS5421326B2 JP S5421326 B2 JPS5421326 B2 JP S5421326B2 JP 7490277 A JP7490277 A JP 7490277A JP 7490277 A JP7490277 A JP 7490277A JP S5421326 B2 JPS5421326 B2 JP S5421326B2
- Authority
- JP
- Japan
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/20—Carbocyclic rings
- C07H15/22—Cyclohexane rings, substituted by nitrogen atoms
- C07H15/222—Cyclohexane rings substituted by at least two nitrogen atoms
- C07H15/226—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings
- C07H15/234—Cyclohexane rings substituted by at least two nitrogen atoms with at least two saccharide radicals directly attached to the cyclohexane rings attached to non-adjacent ring carbon atoms of the cyclohexane rings, e.g. kanamycins, tobramycin, nebramycin, gentamicin A2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Saccharide Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB15421/76A GB1530201A (en) | 1976-04-14 | 1976-04-14 | Process for the preparation of aminoglycoside antibiotics and intermediates therefor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS535141A JPS535141A (en) | 1978-01-18 |
| JPS5421326B2 true JPS5421326B2 (ja) | 1979-07-30 |
Family
ID=10058845
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4246577A Granted JPS52139044A (en) | 1976-04-14 | 1977-04-13 | Process for manufacture of aminoglycoside series antibiotics and new intermediates thereof and process for manufacture thereof |
| JP7490277A Granted JPS535141A (en) | 1976-04-14 | 1977-06-23 | New intermediates of aminoglycoside and process for manufacture thereof |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP4246577A Granted JPS52139044A (en) | 1976-04-14 | 1977-04-13 | Process for manufacture of aminoglycoside series antibiotics and new intermediates thereof and process for manufacture thereof |
Country Status (28)
| Country | Link |
|---|---|
| JP (2) | JPS52139044A (ja) |
| AR (1) | AR219074A1 (ja) |
| AT (1) | AT356267B (ja) |
| AU (1) | AU497416B2 (ja) |
| BE (1) | BE853564A (ja) |
| BG (2) | BG27759A3 (ja) |
| CA (1) | CA1083568A (ja) |
| CH (1) | CH622528A5 (ja) |
| CS (1) | CS202570B2 (ja) |
| DD (2) | DD130661A5 (ja) |
| DE (1) | DE2716533C3 (ja) |
| DK (1) | DK164277A (ja) |
| EG (1) | EG12909A (ja) |
| ES (1) | ES457793A1 (ja) |
| FI (1) | FI771144A (ja) |
| FR (1) | FR2348223A1 (ja) |
| GB (1) | GB1530201A (ja) |
| GR (1) | GR68936B (ja) |
| IE (1) | IE45030B1 (ja) |
| IL (1) | IL51775A (ja) |
| LU (1) | LU77108A1 (ja) |
| NL (1) | NL7703567A (ja) |
| NZ (1) | NZ183733A (ja) |
| PH (1) | PH14029A (ja) |
| PL (2) | PL112867B1 (ja) |
| PT (1) | PT66422B (ja) |
| RO (2) | RO79969A (ja) |
| ZA (1) | ZA771944B (ja) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0414628Y2 (ja) * | 1984-12-13 | 1992-04-02 | ||
| KR20170023817A (ko) | 2014-06-25 | 2017-03-06 | 이에이 파마 가부시키가이샤 | 고형 제제 및 그의 안정화 방법 |
| US10441604B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Cholestyramine pellets and methods for preparation thereof |
| US10441605B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US10487111B2 (en) | 2010-11-08 | 2019-11-26 | Albireo Ab | IBAT inhibitors for the treatment of liver diseases |
| US10519120B2 (en) | 2014-10-24 | 2019-12-31 | Elobix Ab | Crystal modifications of elobixibat |
| US10709755B2 (en) | 2014-06-25 | 2020-07-14 | Elobix Ab | Solid formulation and method for preventing or reducing coloration thereof |
| US10722457B2 (en) | 2018-08-09 | 2020-07-28 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US10786529B2 (en) | 2016-02-09 | 2020-09-29 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US11007142B2 (en) | 2018-08-09 | 2021-05-18 | Albireo Ab | Oral cholestyramine formulation and use thereof |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2924659A1 (de) * | 1979-06-19 | 1981-01-22 | Bayer Ag | Pseudotrisaccharide, ihre herstellung und verwendung als arzneimittel |
| JPS61191642U (ja) * | 1985-05-20 | 1986-11-28 | ||
| IT1225484B (it) * | 1987-11-27 | 1990-11-14 | Pierrel Spa | Procedimento di sintesi dell'amikacina |
| CN101481397B (zh) * | 2009-01-23 | 2012-10-31 | 北京大学 | 一种新的卡那霉素a衍生物及其制备方法和用途 |
-
1976
- 1976-04-14 GB GB15421/76A patent/GB1530201A/en not_active Expired
-
1977
- 1977-03-29 IL IL51775A patent/IL51775A/xx unknown
- 1977-03-29 AU AU23721/77A patent/AU497416B2/en not_active Expired
- 1977-03-30 ZA ZA00771944A patent/ZA771944B/xx unknown
- 1977-03-30 NZ NZ183733A patent/NZ183733A/xx unknown
- 1977-04-01 NL NL7703567A patent/NL7703567A/xx not_active Application Discontinuation
- 1977-04-12 GR GR53193A patent/GR68936B/el unknown
- 1977-04-12 PH PH19649A patent/PH14029A/en unknown
- 1977-04-12 LU LU77108A patent/LU77108A1/xx unknown
- 1977-04-12 PT PT66422A patent/PT66422B/pt unknown
- 1977-04-12 RO RO77101733A patent/RO79969A/ro unknown
- 1977-04-12 RO RO7790001A patent/RO74431A/ro unknown
- 1977-04-12 FI FI771144A patent/FI771144A/fi not_active Application Discontinuation
- 1977-04-13 DK DK164277A patent/DK164277A/da not_active IP Right Cessation
- 1977-04-13 PL PL1977215139A patent/PL112867B1/pl unknown
- 1977-04-13 JP JP4246577A patent/JPS52139044A/ja active Granted
- 1977-04-13 IE IE761/77A patent/IE45030B1/en unknown
- 1977-04-13 EG EG217/77A patent/EG12909A/xx active
- 1977-04-13 FR FR7711108A patent/FR2348223A1/fr not_active Withdrawn
- 1977-04-13 AR AR267190A patent/AR219074A1/es active
- 1977-04-13 CA CA276,055A patent/CA1083568A/en not_active Expired
- 1977-04-13 PL PL19737277A patent/PL197372A1/xx unknown
- 1977-04-13 BE BE176696A patent/BE853564A/xx unknown
- 1977-04-13 CH CH457377A patent/CH622528A5/fr not_active IP Right Cessation
- 1977-04-14 ES ES457793A patent/ES457793A1/es not_active Expired
- 1977-04-14 CS CS772453A patent/CS202570B2/cs unknown
- 1977-04-14 AT AT261477A patent/AT356267B/de not_active IP Right Cessation
- 1977-04-14 DD DD7700198399A patent/DD130661A5/xx unknown
- 1977-04-14 BG BG7736000A patent/BG27759A3/xx unknown
- 1977-04-14 DE DE2716533A patent/DE2716533C3/de not_active Expired
- 1977-04-14 DD DD77204695A patent/DD135496A5/xx unknown
- 1977-04-14 BG BG7737121A patent/BG28072A4/xx unknown
- 1977-06-23 JP JP7490277A patent/JPS535141A/ja active Granted
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0414628Y2 (ja) * | 1984-12-13 | 1992-04-02 | ||
| US10487111B2 (en) | 2010-11-08 | 2019-11-26 | Albireo Ab | IBAT inhibitors for the treatment of liver diseases |
| US11261212B2 (en) | 2010-11-08 | 2022-03-01 | Albireo Ab | IBAT inhibitors for the treatment of liver diseases |
| US10981952B2 (en) | 2010-11-08 | 2021-04-20 | Albireo Ab | IBAT inhibitors for the treatment of liver diseases |
| US10709755B2 (en) | 2014-06-25 | 2020-07-14 | Elobix Ab | Solid formulation and method for preventing or reducing coloration thereof |
| KR20170023817A (ko) | 2014-06-25 | 2017-03-06 | 이에이 파마 가부시키가이샤 | 고형 제제 및 그의 안정화 방법 |
| KR20220082931A (ko) | 2014-06-25 | 2022-06-17 | 이에이 파마 가부시키가이샤 | 고형 제제 및 그의 착색 방지 또는 착색 감소 방법 |
| US10519120B2 (en) | 2014-10-24 | 2019-12-31 | Elobix Ab | Crystal modifications of elobixibat |
| US10786529B2 (en) | 2016-02-09 | 2020-09-29 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US10758563B2 (en) | 2016-02-09 | 2020-09-01 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US10493096B2 (en) | 2016-02-09 | 2019-12-03 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US10799527B2 (en) | 2016-02-09 | 2020-10-13 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US10864228B2 (en) | 2016-02-09 | 2020-12-15 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US10441604B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Cholestyramine pellets and methods for preparation thereof |
| US10441605B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US10610543B2 (en) | 2016-02-09 | 2020-04-07 | Albireo Ab | Cholestyramine pellets and methods for preparation thereof |
| US10722457B2 (en) | 2018-08-09 | 2020-07-28 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US11007142B2 (en) | 2018-08-09 | 2021-05-18 | Albireo Ab | Oral cholestyramine formulation and use thereof |